Harvard Bioscience misses top-line and bottom-line estimates; initiates Q2 and reaffirms FY26 outlook
Harvard Bioscience Inc · LABORATORY ANALYTICAL INSTRUMENTS · Now $6.40
-3.0% in 3d after detection
Post-detection moves
1h
—
1d
+2.9%
3d
-3.0%
7d
+2.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS